Frontiers in Immunology (Dec 2021)
Corrigendum: A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis
- Wenyan Fu,
- Wenyan Fu,
- Yu Liu,
- Yu Liu,
- Fangjie Liu,
- Fangjie Liu,
- Chenghua Liu,
- Chenghua Liu,
- Jingjing Li,
- Jiali Niu,
- Peng Han,
- Dan Xu,
- Jiaojiao Hou,
- Yuanfang Ma,
- Jiannan Feng,
- Jiannan Feng,
- Zhanguo Li,
- Rong Mu,
- Guang Yang,
- Guang Yang
Affiliations
- Wenyan Fu
- Beijing Institute of Pharmacology and Toxicology, Beijing, China
- Wenyan Fu
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
- Yu Liu
- Beijing Institute of Pharmacology and Toxicology, Beijing, China
- Yu Liu
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
- Fangjie Liu
- Beijing Institute of Pharmacology and Toxicology, Beijing, China
- Fangjie Liu
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
- Chenghua Liu
- Beijing Institute of Pharmacology and Toxicology, Beijing, China
- Chenghua Liu
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
- Jingjing Li
- Joint National Laboratory for Antibody Drug Engineering, Henan University, Kaifeng, China
- Jiali Niu
- Joint National Laboratory for Antibody Drug Engineering, Henan University, Kaifeng, China
- Peng Han
- Department of Rheumatology and Immunology, People’s Hospital, Peking University, Beijing, China
- Dan Xu
- Department of Rheumatology and Immunology, People’s Hospital, Peking University, Beijing, China
- Jiaojiao Hou
- Joint National Laboratory for Antibody Drug Engineering, Henan University, Kaifeng, China
- Yuanfang Ma
- Joint National Laboratory for Antibody Drug Engineering, Henan University, Kaifeng, China
- Jiannan Feng
- Beijing Institute of Pharmacology and Toxicology, Beijing, China
- Jiannan Feng
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
- Zhanguo Li
- Department of Rheumatology and Immunology, People’s Hospital, Peking University, Beijing, China
- Rong Mu
- Department of Rheumatology and Immunology, People’s Hospital, Peking University, Beijing, China
- Guang Yang
- Beijing Institute of Pharmacology and Toxicology, Beijing, China
- Guang Yang
- State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, China
- DOI
- https://doi.org/10.3389/fimmu.2021.819846
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
